Medicine and Dentistry
Ganglioneuroblastoma
100%
High Dose Chemotherapy
68%
Pediatrics
63%
Autologous Stem Cell Transplantation
53%
Pediatrics Patient
53%
Childhood Cancer
48%
Overall Survival
47%
Diseases
40%
Neoplasm
39%
Radiation Therapy
35%
Craniospinal Irradiation
31%
Hematopoietic Stem Cell Transplantation
30%
Clinical Significance
29%
Osteosarcoma
28%
Survival Rate
28%
Acute Lymphoblastic Leukemia
28%
Next Generation Sequencing
27%
Event Free Survival
26%
Solid Malignant Neoplasm
23%
Cord Blood
20%
Cytomegalovirus Infection
20%
Survivorship in Cancer Care
20%
Medulloblastoma
20%
Prognostic Factor
20%
Progression Free Survival
19%
Patient with Neuroblastoma
18%
Cord Blood Stem Cell Transplantation
18%
Gene Mutation
15%
Induction Chemotherapy
15%
Retinoblastoma
15%
(3 Iodobenzyl)guanidine
14%
Atypical Teratoid Rhabdoid Tumor
14%
Cancer
13%
Aplastic Anemia
13%
Langerhans Cell Histiocytosis
13%
Pediatric Acute Myeloid Leukemia
13%
Influenza Vaccination
13%
Biological Marker
13%
Severe Myoclonic Epilepsy of Infancy
13%
Medical Record
13%
Cytomegalovirus
13%
Malignant Neoplasm
13%
Engraftment
12%
Epileptic Seizure
11%
Magnetic Resonance Imaging
11%
Oncologist
10%
Treatment Response
9%
Metastatic Carcinoma
8%
Acute Myeloid Leukemia
8%
Primary Tumor
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
55%
Neuroblastoma
52%
High Dose Chemotherapy
43%
Chemotherapy
42%
Solid Malignant Neoplasm
40%
Overall Survival
34%
Fludarabine
34%
Busulfan
34%
Diseases
27%
Neoplasm
27%
Therapeutic Drug Monitoring
25%
Survival Rate
24%
Malignant Neoplasm
22%
Medulloblastoma
20%
Mercaptopurine
19%
Cyclophosphamide
17%
Osteosarcoma
15%
Systemic Mycosis
14%
Event Free Survival
13%
Aplastic Anemia
13%
Methotrexate Polyglutamate
13%
Voriconazole
13%
Spinal Muscular Atrophy
13%
Nusinersen
13%
Atypical Teratoid Rhabdoid Tumor
13%
Tioguanine
13%
Progression Free Survival
13%
Neutropenia
13%
Cisplatin
12%
Remission
12%
Iobenguane
12%
Pharmacokinetic
11%
Cytomegalovirus Infection
10%
Prospective Study
9%
Etoposide
8%
Clinical Study
8%
Biological Marker
8%
Hematologic Malignancy
8%
Receptor
7%
Iron Chelating Agent
7%
Antifungal Therapy
7%
Febrile Neutropenia
7%
Sodium Channel Blocking Agent
6%
Kasabach Merritt Syndrome
6%
Methionine C 11
6%
Germ Cell Tumor
6%
Pegteograstim
6%
Gemcitabine
6%
Vanillylmandelic Acid
6%
Homovanillic Acid
6%
Immunology and Microbiology
Drug Megadose
62%
Autologous Stem Cell Transplantation
43%
Overall Survival
42%
Survival Rate
31%
Cord Blood Stem Cell Transplantation
30%
Event Free Survival
29%
Engraftment
28%
Conditioning
27%
Cytomegalovirus Infection
25%
Cytomegalovirus
23%
Progression Free Survival
21%
Medical Record
21%
Hematopoietic Stem Cell Transplantation
20%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Graft-Versus-Host Disease
19%
Hematopoietic Cell
18%
Neutrophil Count
14%
Langerhans Cell
13%
Myeloid
13%
Cell Transplantation
11%
Next Generation Sequencing
11%
Interferon
11%
Neutrophil
10%
Iobenguane
9%
Cyclophosphamide
9%
Polymerase Chain Reaction
9%
Varicella Zoster Virus
9%
Gene Mutation
9%
Iodine-131
8%
Primary Immunodeficiency
8%
Tumor Volume
8%
Severe Combined Immunodeficiency
7%
NOD SCID Mouse
7%
Chronic Granulomatous Disease
7%
Aplastic Anemia
6%
Methionine
6%
Soft Tissue
6%
Myostatin
6%
Positron Emission Tomography-Computed Tomography
6%
Bone Tissue
6%
Engraftment Syndrome
6%
Adipose Tissue
6%
Clinical Immunology
6%
Vertebra
6%
Granulocyte
6%
Kidney Concentrating Capacity
6%
Immunosuppressive Drug
6%
Stem Cell Transplantation
6%
Isotretinoin
6%
TNF related apoptosis inducing ligand
6%